Skip to main content
31°
Clear
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Zynerba Pharma CS
(NQ:
ZYNE
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Oct 10, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
1.300 (10)
Ask (Size)
1.370 (10)
Prev. Close
1.300
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
53,939,431
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Shares of Harmony Bioscience Are Falling on Friday
October 13, 2023
The company reported underwhelming phase 3 trial results for Pitolisant to treat idiopathic hypersomnia.
Via
The Motley Fool
New Possibilities For Cannabinoid Treatments: Acquisition To Transform Neuropsychiatric Disorder Therapies
October 11, 2023
Healthcare company Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) completed its previously announced acquisition of Zynerba Pharmaceuticals, Inc.
Via
Benzinga
Performance
More News
Read More
Important Information for Zynerba Pharmaceuticals Stockholders to Tender Shares for the Harmony Transaction: Process and Instructions
October 04, 2023
From
Zynerba Pharmaceuticals, Inc.
Via
GlobeNewswire
Zynerba Pharmaceuticals Stockholders Reminded to Tender Shares Before 5:00 PM New York City Time, on Tuesday October 10, 2023
September 29, 2023
From
Zynerba Pharmaceuticals, Inc.
Via
GlobeNewswire
Bearish Sentiment Across The Cannabis Space - Check Full Movers For September 26, 2023
September 26, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Movers For September 18, 2023
September 18, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Zynerba Pharmaceuticals Presents Positive Data from Phase 2 INSPIRE Trial in 22q11.2 Deletion Syndrome at The Society for the Study of Behavioural Phenotypes (SSBP) 25th International Research Symposium
September 14, 2023
From
Zynerba Pharmaceuticals, Inc.
Via
GlobeNewswire
ZYNERBA PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Zynerba Pharmaceuticals, Inc. - ZYNE
September 05, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sovos Brands, Inc. (Nasdaq - SOVO), Zynerba Pharmaceuticals, Inc. (Nasdaq - ZYNE), Computer Task Group, Incorporated (Nasdaq - CTG), Decibel Therapeutics, Inc.
August 24, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
Cannabis Stock Movers For August 18, 2023
August 18, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023
August 21, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2023
August 16, 2023
Via
Benzinga
Cannabis Stock Gainers And Losers From August 16, 2023
August 16, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Occidental Petroleum To Rally Around 18%? Here Are 10 Other Analyst Forecasts For Wednesday
August 16, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2023
August 15, 2023
Via
Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Zynerba Pharmaceuticals, Inc. (Nasdaq - ZYNE), Chindata Group Holdings Limited (Nasdaq - CD), Capri Holdings Limited (NYSE – CPRI), Avid® (Nasdaq - AVID)
August 14, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
Cannabis Stock Gainers And Losers From August 14, 2023
August 14, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Crude Oil Down 1%; Zynerba Pharmaceuticals Shares Spike Higher
August 14, 2023
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Is Zynerba Pharmaceuticals (ZYNE) Stock Up 270% Today?
August 14, 2023
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
August 14, 2023
Via
Benzinga
Why 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 14, 2023
Via
Benzinga
US Stocks Turn Higher; BioXcel Therapeutics Shares Plummet
August 14, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Health Care Company Harmony Biosciences Announces Acquisition of Zynerba Pharmaceuticals
August 14, 2023
Via
Benzinga
Why Zynerba Pharmaceuticals Stock Is Skyrocketing Today?
August 14, 2023
Via
Benzinga
Dow Falls 50 Points; Monday.com Posts Upbeat Results
August 14, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
